These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20824513)

  • 1. Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.
    Badshah A; Subhan F; Rauf K
    AAPS PharmSciTech; 2010 Sep; 11(3):1397-404. PubMed ID: 20824513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Rauf K; Bukhari NI; Shah K; Khan S; Ahmed Z; Khan I
    AAPS PharmSciTech; 2011 Jun; 12(2):525-33. PubMed ID: 21494924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU
    Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: an in vitro and in vivo evaluation.
    Shah KU; Khan GM
    ScientificWorldJournal; 2012; 2012():842348. PubMed ID: 22649325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.
    Khan KA; Khan GM; Zeeshan Danish M; Akhlaq ; Khan H; Rehman F; Mehsud S
    Int J Pharm; 2015 Dec; 496(2):759-65. PubMed ID: 26545310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
    Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic Approach to Understanding the Influence of USP Apparatus I and II on Dissolution Kinetics of Tablets with Different Operating Release Mechanisms.
    Lu Z; Fassihi R
    AAPS PharmSciTech; 2017 Feb; 18(2):462-472. PubMed ID: 27106916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of controlled release tablet performance and hydrogel strength on in vitro/in vivo correlation.
    Roshdy MN; Schnaare RL; Sugita ET; Schwartz JB
    Pharm Dev Technol; 2002 May; 7(2):155-68. PubMed ID: 12066571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and rapid approach to evaluate the in vitro in vivo role of release controlling agent ethyl cellulose ether derivative polymer.
    Akhlaq M; Khan GM; Jan SU; Wahab A; Hussain A; Nawaz A; Abdelkader H
    Pak J Pharm Sci; 2014 Nov; 27(6):1789-98. PubMed ID: 25362603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hydroxypropyl methylcellulose mixture, apparent viscosity, and tablet hardness on drug release using a 2(3) full factorial design.
    Khanvilkar KH; Huang Y; Moore AD
    Drug Dev Ind Pharm; 2002 May; 28(5):601-8. PubMed ID: 12098849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To study the influence of different grades of Ethylcellulose ether derivative polymer Ethocel® and co-excipient on drug release profile of controlled release matrix tablet of acarbose.
    Mehsud S; Rauf M; Obaidullah -; Khan KA; Khan GM
    Pak J Pharm Sci; 2015 Nov; 28(6 Suppl):2259-65. PubMed ID: 26687743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
    Saravanan M; Sri Nataraj K; Ganesh KS
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and in vitro, in vivo evaluation of effervescent floating sustained-release imatinib mesylate tablet.
    Kadivar A; Kamalidehghan B; Javar HA; Davoudi ET; Zaharuddin ND; Sabeti B; Chung LY; Noordin MI
    PLoS One; 2015; 10(6):e0126874. PubMed ID: 26035710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet.
    Mourão SC; da Silva C; Bresolin TM; Serra CH; Porta V
    Int J Pharm; 2010 Feb; 386(1-2):201-7. PubMed ID: 19941944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
    Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
    Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
    Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
    Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of oseltamivir phosphate dual-phase extended-release tablets for the treatment of influenza.
    Yu L; Huang X; Jiang M; Guo W; Li X; Huang F; You J
    Int J Pharm; 2024 Aug; 661():124364. PubMed ID: 38914352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.